Assessment of Cost-Effectiveness Models for Biologics in the Management of Severe Ankylosing Spondylitis

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.2223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Self-Management Programme for Ankylosing Spondylitis

2008English

Management of Ankylosing Spondylitis With Infliximab

Open Access Rheumatology: Research and Reviews
Rheumatology
2009English

Alternative Anaesthetic Management in Ankylosing Spondylitis

Agri Dergisi
AnesthesiologyPain Medicine
2014English

A New Method for the Radiological Assessment of Vertebral Squaring in Ankylosing Spondylitis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1992English

Ankylosing Spondylitis

2019English

Ankylosing Spondylitis

2019English

Turkish League Against Rheumatism National Recommendations for the Management of Ankylosing Spondylitis

Turkish Journal of Rheumatology
2011English

Recent Advances in Ankylosing Spondylitis: Understanding the Disease and Management

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy